51. The inflammation-lipocalin 2 axis may contribute to the development of chronic kidney disease.
- Author
-
Hashikata A, Yamashita A, Suzuki S, Nagayasu S, Shinjo T, Taniguchi A, Fukushima M, Nakai Y, Nin K, Watanabe N, Asano T, Abiko Y, Kushiyama A, Nagasaka S, and Nishimura F
- Subjects
- Acute-Phase Proteins metabolism, Adult, Aged, Aged, 80 and over, Animals, Biomarkers metabolism, Cell Line, Coculture Techniques, Creatinine blood, Female, Humans, Inflammation metabolism, Lipocalin-2, Lipocalins metabolism, Male, Mice, Middle Aged, Oligonucleotide Array Sequence Analysis, Proto-Oncogene Proteins metabolism, Receptors, Tumor Necrosis Factor, Type II metabolism, Renal Insufficiency, Chronic genetics, Renal Insufficiency, Chronic immunology, Transcriptome, Acute-Phase Proteins genetics, Lipocalins genetics, Proto-Oncogene Proteins genetics, Renal Insufficiency, Chronic metabolism
- Abstract
Background: Chronic kidney disease (CKD) is an important risk factor for coronary heart disease, and previous studies indicated the involvement of low-grade inflammation in the pathogenesis of CKD., Methods: The study was designed to (i) identify and confirm genes and their products upregulated in mesangial cells cocultured with endotoxin-stimulated macrophages and (ii) determine the clinical relevance of genes and proteins upregulated in mesangial cells under inflammatory conditions by an epidemiological approach., Results: DNA microarray analysis revealed upregulated expression of many genes and their products including several cytokines and chemokines, as well as the inflammatory marker, lipocalin 2 gene. The gene expression and protein upregulation of lipocalin 2 were synergistically affected by endotoxin and tumor necrosis factor (TNF)-α stimulation. In human studies, lipocalin 2 level was significantly associated with creatinine (r = 0.419, P < 0.001) and negatively associated with eGFR (r = -0.365, P < 0.001). Multiple logistic regression analysis revealed a significant association between lipocalin 2 and soluble tumor necrosis factor receptor 2 (sTNF-R2), eGFR and uric acid in general subjects attending regular annual medical check-up (n = 420). When subjects with diabetes were excluded from the analysis, lipocalin 2 remained associated with sTNF-R2, eGFR and uric acid., Conclusions: Since an activated TNF system, as demonstrated by elevated sTNF-R2, and elevated uric acid were recently implicated in an elevated CKD risk, we conclude that inflammation could play an important role in the pathogenesis of CKD, and that lipocalin 2 is a potential universal marker for impaired kidney function. Furthermore, the results obtained by the current microarray analysis could improve the understanding of gene profiles associated with the pathophysiology of CKD under inflammatory conditions.
- Published
- 2014
- Full Text
- View/download PDF